Clinical impact of CD25 expression on outcomes of allogeneic hematopoietic stem cell transplant for cytogenetically intermediate-risk acute myeloid leukemia

Leuk Lymphoma. 2015 Jun;56(6):1874-7. doi: 10.3109/10428194.2014.974044. Epub 2014 Nov 14.

Authors

Shuntaro Ikegawa¹, Noriko Doki, Keita Yamamoto, Naoki Shingai, Yukie Takahashi, Jun Aoki, Kosuke Yoshioka, Kensuke Narukawa, Shinya Ishida, Aiko Igarashi, Gaku Oshikawa, Takeshi Kobayashi, Kazuhiko Kakihana, Hisashi Sakamaki, Kyoko Haraguchi, Yoshiki Okuyama, Kazuteru Ohashi

Affiliation

¹ Hematology Division.

PMID: 25311493
DOI: 10.3109/10428194.2014.974044

No abstract available

Publication types

Letter

MeSH terms

Acute Disease
Adult
Disease-Free Survival
Flow Cytometry
Hematopoietic Stem Cell Transplantation / methods*
Humans
Interleukin-2 Receptor alpha Subunit / metabolism*
Kaplan-Meier Estimate
Karyotype
Leukemia, Myeloid / genetics
Leukemia, Myeloid / metabolism
Leukemia, Myeloid / therapy*
Middle Aged
Multivariate Analysis
Outcome Assessment, Health Care / methods
Outcome Assessment, Health Care / statistics & numerical data
Prognosis
Proportional Hazards Models
Risk Factors
Transplantation, Homologous

Substances

Interleukin-2 Receptor alpha Subunit